cytokinetics News
Most Popular cytokinetics Story
Amgen inks $650M deal, dives into cardio field
Impressed by new data on Cytokinetics' experimental heart failure drug, Amgen has decided to exercise its option to buy the rights to the therapy. The biotech giant-which paid $75 million for the Read more...
Latest Headlines
- November 30, 2011
- August 19, 2011
- March 10, 2010
- December 10, 2009
- May 26, 2009
- September 24, 2008
- September 16, 2008
- June 20, 2008
- October 16, 2007
- September 11, 2007
- June 28, 2007
- January 3, 2007
- January 2, 2007
- November 27, 2006
- October 2, 2006
- March 30, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
